1. Myelodysplastic Syndromes Showing Slight Monocytic Marrow Proliferation Are Prone to Progress to CMML. (April 2017) Authors: Schuler, E.; Frank, F.; Betz, B.; Hildebrandt, B.; Aul, C.; Strupp, C.; Schroeder, T.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML. (February 2018) Authors: Schuler, E.; Frank, F.; Hildebrandt, B.; Betz, B.; Strupp, C.; Rudelius, M.; Aul, C.; Schroeder, T.; Gattermann, N.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 65(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Validation of a New Clinically Based Classification System for Stratification of Prognosis in Patients with CMML. (April 2017) Authors: Rautenberg, C.; Schuler, E.; Nachtkamp, K.; Schroeder, T.; Blum, S.; Aul, C.; Haas, R.; Germing, U. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Who Classification 2016 for the Myelodysplastic Syndromes (MDS): Main Changes. (April 2017) Authors: Strupp, C.; Aul, C.; Germing, U. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗